Click here to view cell apoptosis assay products
×

SARS-CoV-2 Neutralization Antibody ELISA Kit

  • Cat.No.:E-EL-E608

  • Reactivity: Human
  • Assay Type: One step Competitive-ELISA
  • Assay time: 1.5h

To Purchase E-EL-E608

Size:
  • 96T
  • 48T
  • 24T
  • 96T*5
  • 96T*10
Price: $620
Qty:

Properties

Format 24T, 96T, 96T*5, 96T*10
Assay time 1.5h
Sample type serum and plasma
Sample volume 50 μL
Storage 2-8℃
Interpretation Semi-Quantitative
Application This ELISA kit applies to the in vitro Semi-Quantitative determination of SARS-CoV-2 Neutralization Antibody in serum or plasma.
Reproducibility Both intra-CV and inter-CV are < 10%
Synonyms COVID 19 Neutralization Antibody, Anti-RBD, RBD Antibody, S1RBD Antibody

Test Principle

This ELISA kit uses Competitive-ELISA as the method to qualitatively detect the Anti-SARS-CoV-2 Neutralization Antibody in the sample. _x000D_ The micro ELISA plate provided in this kit is pre-coated with recombinant human ACE2. During the reaction, the SARS-CoV-2 Neutralization Antibody in the pretreated samples or controls competes with a fixed amount of human ACE2 on the solid phase supporter for sites on the Horseradish peroxidase (HRP) conjugated recombinant SARS-CoV-2 RBD fragment (HRP-RBD). After 37℃ incubation, the unbound HRP-RBD as well as any HRP-RBD bound to non-Neutralization antibody will be captured on the plate and eventually form the ACE2-RBD-HRP complex, while the circulating neutralization antibodies HRP-RBD complexes remain in the supernatant and are removed during washing. Then a TMB substrate solution is added to each well. The enzyme-substrate reaction is terminated by the addition of stop solution and the color change is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. Compared with the inhibition ratio to judge whether SARS-CoV-2 Neutralization Antibody exists in the tested samples or not.

Assay Procedures

Citations

  1. Cells (2022) IF: 6.6
    Venetoclax Decreases the Expression of the Spike Protein through Amino Acids Q493 and S494 in SARS-CoV-2

    DOI: 10.3390/cells11121924

    PMID: 35741053

    Sample: Hek293T Cell
  2. Healthcare (2023) IF: 3.16
    Evaluation of Convalescent Plasma in the Management of Critically Ill COVID-19 Patients (with No Detectable Neutralizing Antibodies Nab) in Kashmir, India

    DOI: 10.3390/healthcare11030317

    Sample: Plasma
  3. JOURNAL OF INTERNAL MEDICINE (2022) IF: 8.989
    Randomized clinical trial of BCG vaccine in patients with convalescent COVID-19: Clinical evolution, adverse events, and humoral immune response

    DOI: 10.1111/joim.13523

    PMID: 35599154

    Sample: Plasma
Show AllShorten

Reviews/Q&A

  • Show all
  • Reviews
  • Q&A
Q

E***************oSubmitted [ Dec 13 2023 ]

Asked: Hi I would like to know wether your kit SARS-CoV-2 Neutralization Antibody ELISA Kit Cat.No.:E-EL-E608 measures neutralizing Abs against XBB 1.5. I would also like to know if it can be used for assessing neutlalizing antibodies in clinical trials of novel COVID-19 vaccines.

Reply

A

adminSubmitted [ Dec 13 2023 ]

Answered: Theoretically, the E-EL-E608 kit can be used to measure the neutlalizing antibodies against XBB 1.5 and neutlalizing antibodies in clinical trials of novel COVID-19 vaccines. However, since we have not done similar verification, it is recommended that you confirm the actual detection effect through pre-test before formal experiment.

... Show All Show Less

People Also Bought

Apply for Free Shipping 24T ELISA Kit
*Product Name:
*Catalog Number:
Size:
*Name:
*Email:
*Phone:
*Message:
*Country:
*When will you use it?

*Captcha: